TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.59B
AUM Growth
-$205M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
169
New
Increased
Reduced
Closed

Top Buys

1
+$42.1M
2
+$23.4M
3
+$21.4M
4
CELG
Celgene Corp
CELG
+$13.2M
5
SAGE
Sage Therapeutics
SAGE
+$11.2M

Top Sells

1
+$25.8M
2
+$23.6M
3
+$21.4M
4
GILD icon
Gilead Sciences
GILD
+$20.1M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$18.4M

Sector Composition

1 Healthcare 92.75%
2 Real Estate 2.87%
3 Financials 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$11.8M 0.46%
388,822
52
$11.2M 0.43%
+67,815
53
$10.1M 0.39%
44,918
54
$9.69M 0.37%
82,709
+12,875
55
$9.39M 0.36%
85,804
-41,296
56
$9.28M 0.36%
479,150
57
$9.13M 0.35%
209,673
+73,461
58
$9.04M 0.35%
310,250
59
$8.89M 0.34%
272,400
60
$8.71M 0.34%
604,920
+329,426
61
$8.58M 0.33%
+47,566
62
$8.39M 0.32%
3,636
+2,611
63
$7.88M 0.3%
+144,072
64
$7.79M 0.3%
70,347
+60,347
65
$7.74M 0.3%
179,900
66
$7.47M 0.29%
268,500
-128,400
67
$7.4M 0.29%
+245,885
68
$7.34M 0.28%
195,300
-96,900
69
$7.09M 0.27%
914,548
70
$6.89M 0.27%
148,558
71
$6.87M 0.26%
117,437
-44,139
72
$6.68M 0.26%
883,919
+315,922
73
$6.56M 0.25%
+264,600
74
$6.52M 0.25%
332,850
+91,829
75
$6.49M 0.25%
+128,930
1 2
3
4 5